Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastasis From Non-small Cell Lung Cancer: A Prospective Pilot Clinical Trial

NCT03101579 is registered in ClinicalTrials.gov with The First Hospital of Jilin University as lead sponsor.

NCT NCT03101579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03101579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastasis From Non-small Cell Lung Cancer: A Prospective Pilot Clinical Trial
Lead sponsor
The First Hospital of Jilin University
Phase
Phase 1
Overall status
Completed
Start date
March 1, 2017
Completion date
January 5, 2019
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leptomeningeal metastases